INVIVO THERAPEUTICS HOLDING CORP | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
INVIVO THERAPEUTICS HOLDING CORP | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
INVIVO THERAPEUTICS HOLDING CORP | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Macro Fund, LP(3.9%),Lind Global Partners LLC(3.9%), etc.
InVivo Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Foose Brice
InVivo Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Foose Brice
InVivo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brice Foose(0%)
InVivo Therapeutics | 8-K: Current report
InVivo Therapeutics | 8-K: Current report
InVivo Therapeutics | 8-K: Current report
InVivo Therapeutics | ARS: Annual Report to Security Holders
InVivo Therapeutics | DEF 14A: Definitive information statements
InVivo Therapeutics | 8-K: Current report
InVivo Therapeutics | 8-K: Current report
InVivo Therapeutics | 8-K: Current report
InVivo Therapeutics | 10-Q: Q3 2023 Earnings Report
InVivo Therapeutics | 8-K: Current report
InVivo Therapeutics | 10-Q: Q2 2023 Earnings Report
InVivo Therapeutics | 10-Q: Q1 2023 Earnings Report
InVivo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Brice Foose(11.5%)
InVivo Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Foose Brice